Anaplastic Large Cell Lymphoma of the Breast Arising Around Mammary Implant Capsule: An Italian Report

Abstract

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Breast Implant–Associated Anaplastic Large Cell Lymphoma

“…[11][12][13][14][15][16][17] Moreover, all breast implant-associated ALCLs are ALK − compared with systemic ALCL, where the cases can present as ALK+ or as ALK − . Finally, prognosis differs drastically between systemic ALK − ALCL and breast implant-associated ALCL, with the former being an aggressive disease and the latter having a more indolent course.…”

What’s new on primary Hodgkin’s lymphoma of the breast? A case report and review of the literature

“…For what concerns primary T-cell lymphoma of the breast, the 80% is represented by Ana- plastic Large Cell Lymphoma (ALLC), which could also be caused by breast implant in breast reconstruction [7] , [8] , and the remaining 20% by Hodgkin Lymphoma (LH) [9] , [10] .…”

Resultados De Un Programa De Seguimiento De Las Prótesis Mamarias Pip (Poly-Implant-Prothese)

“…Sin embargo, la máxima preocupación se ha centrado ahora en la seguridad del dispositivo, la longevidad y una posible asociación con el desarrollo de neoplasias, sobre todo del linfoma anaplásico de células grandes (LACG), aunque su relación parece ser la misma con todas las marcas de prótesis 6 . no obstante, no existe evidencia suficiente que muestre riesgos sanitarios superiores de las prótesis PIP frente a otras prótesis mamarias para las portadoras de estos implantes 7,8 .…”